Literature DB >> 27989445

The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.

Samuel Y Ash1, Rola Harmouche2, James C Ross2, Alejandro A Diaz3, Gary M Hunninghake3, Rachel K Putman3, Jorge Onieva2, Fernando J Martinez4, Augustine M Choi4, David A Lynch5, Hiroto Hatabu6, Ivan O Rosas3, Raul San Jose Estepar2, George R Washko3.   

Abstract

RATIONALE AND
OBJECTIVES: Previous investigation suggests that visually detected interstitial changes in the lung parenchyma of smokers are highly clinically relevant and predict outcomes, including death. Visual subjective analysis to detect these changes is time-consuming, insensitive to subtle changes, and requires training to enhance reproducibility. Objective detection of such changes could provide a method of disease identification without these limitations. The goal of this study was to develop and test a fully automated image processing tool to objectively identify radiographic features associated with interstitial abnormalities in the computed tomography scans of a large cohort of smokers.
MATERIALS AND METHODS: An automated tool that uses local histogram analysis combined with distance from the pleural surface was used to detect radiographic features consistent with interstitial lung abnormalities in computed tomography scans from 2257 individuals from the Genetic Epidemiology of COPD study, a longitudinal observational study of smokers. The sensitivity and specificity of this tool was determined based on its ability to detect the visually identified presence of these abnormalities.
RESULTS: The tool had a sensitivity of 87.8% and a specificity of 57.5% for the detection of interstitial lung abnormalities, with a c-statistic of 0.82, and was 100% sensitive and 56.7% specific for the detection of the visual subtype of interstitial abnormalities called fibrotic parenchymal abnormalities, with a c-statistic of 0.89.
CONCLUSIONS: In smokers, a fully automated image processing tool is able to identify those individuals who have interstitial lung abnormalities with moderate sensitivity and specificity.
Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT scanner; Pulmonary fibrosis; cigarettes; diffuse parenchymal lung diseases; idiopathic; interstitial; pneumonia; x-ray

Mesh:

Year:  2016        PMID: 27989445      PMCID: PMC5472510          DOI: 10.1016/j.acra.2016.08.023

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  27 in total

1.  Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment.

Authors:  Alan C Best; Anne M Lynch; Carmen M Bozic; David Miller; Gary K Grunwald; David A Lynch
Journal:  Radiology       Date:  2003-06-11       Impact factor: 11.105

2.  High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease.

Authors:  P G Hartley; J R Galvin; G W Hunninghake; J A Merchant; S J Yagla; S B Speakman; D A Schwartz
Journal:  J Appl Physiol (1985)       Date:  1994-01

3.  EMPHYSEMA QUANTIFICATION IN A MULTI-SCANNER HRCT COHORT USING LOCAL INTENSITY DISTRIBUTIONS.

Authors:  C S Mendoza; G R Washko; J C Ross; A A Diaz; D A Lynch; J D Crapo; E K Silverman; B Acha; C Serrano; R San José Estépar
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2012

Review 4.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors:  George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal:  Acad Radiol       Date:  2009-09-24       Impact factor: 3.173

6.  Assessment of prognosis of patients with idiopathic pulmonary fibrosis by computer-aided analysis of CT images.

Authors:  Tae Iwasawa; Akira Asakura; Fumikazu Sakai; Tetu Kanauchi; Toshiyuki Gotoh; Takashi Ogura; Takuya Yazawa; Junichi Nishimura; Tomio Inoue
Journal:  J Thorac Imaging       Date:  2009-08       Impact factor: 3.000

7.  Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality.

Authors:  Alan C Best; Jiangfeng Meng; Anne M Lynch; Carmen M Bozic; David Miller; Gary K Grunwald; David A Lynch
Journal:  Radiology       Date:  2008-01-30       Impact factor: 11.105

8.  Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

Authors:  Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

9.  Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.

Authors:  Tracy J Doyle; Paul F Dellaripa; Kerri Batra; Michelle L Frits; Christine K Iannaccone; Hiroto Hatabu; Mizuki Nishino; Michael E Weinblatt; Dana P Ascherman; George R Washko; Gary M Hunninghake; Augustine M K Choi; Nancy A Shadick; Ivan O Rosas
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

10.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

View more
  17 in total

1.  Objectively Measured Chronic Lung Injury on Chest CT.

Authors:  Rola Harmouche; Samuel Y Ash; Rachel K Putman; Gary M Hunninghake; Ruben San Jose Estepar; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; MeiLan K Han; Russell P Bowler; Ravi Kalhan; Ivan O Rosas; George R Washko; Raul San Jose Estepar
Journal:  Chest       Date:  2019-06-22       Impact factor: 9.410

2.  Toward Early Identification of Clinically Relevant Interstitial Lung Disease.

Authors:  Margaret L Salisbury; David A Lynch
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

3.  Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Farbod N Rahaghi; Gonzalo Vegas Sanchez-Ferrero; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie L Pistenmaa; Alejandro A Diaz; James C Ross; Stephen Rennard; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Radiology       Date:  2020-05-05       Impact factor: 11.105

4.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

5.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

6.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

Review 7.  Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study.

Authors:  Surya P Bhatt; George R Washko; Eric A Hoffman; John D Newell; Sandeep Bodduluri; Alejandro A Diaz; Craig J Galban; Edwin K Silverman; Raúl San José Estépar; David A Lynch
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

8.  Progress and Research Priorities in Imaging Genomics for Heart and Lung Disease: Summary of an NHLBI Workshop.

Authors:  Donna K Arnett; Ramachandran S Vasan; Matthew Nayor; Li Shen; Gary M Hunninghake; Peter Kochunov; R Graham Barr; David A Bluemke; Ulrich Broeckel; Peter Caravan; Susan Cheng; Paul S de Vries; Udo Hoffmann; Márton Kolossváry; Huiqing Li; James Luo; Elizabeth M McNally; George Thanassoulis
Journal:  Circ Cardiovasc Imaging       Date:  2021-08-13       Impact factor: 8.589

9.  Study protocol for a national cohort of adults focused on respiratory health: the American Lung Association Lung Health Cohort (ALA-LHC) Study.

Authors:  Paul A Reyfman; Elizabeth Sugar; Heather Hazucha; Jenny Hixon; Curt Reynolds; Sonali Bose; Mark T Dransfield; MeiLan K Han; Raul San Jose Estepar; Mary B Rice; George R Washko; Mercedes Carnethon; Ravi Kalhan
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 3.006

Review 10.  Interstitial Lung Abnormalities: State of the Art.

Authors:  Akinori Hata; Mark L Schiebler; David A Lynch; Hiroto Hatabu
Journal:  Radiology       Date:  2021-08-10       Impact factor: 29.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.